Redmile Group, LLC, 10% Owner at ARRAY BIOPHARMA INC (ARRY), bought 782,592 shares at $4.50 ($3.6M) on 2015-10-01, disclosed to the SEC on 2015-10-01.
Open-market purchase of $3.6M ARRY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.56 | 500,000 | $2.3M | 63.6% |
| 2 | $4.67 | 182,452 | $852K | 23.8% |
| 3 | $4.50 | 100,140 | $451K | 12.6% |
| Total | $4.58 avg | 782,592 | $3.6M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |